BCI Marketplace
Depression Neuromodulation trials

Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome

RecruitingNCT06720571Phase: NAStarted 2023-11-22

Summary

The STIM-PRADER study aims to assess the effectiveness of auricular vagal neuromodulation therapy (aVNT) on emotional, behavioral, and cognitive domains impaired in Prader-Willi Syndrome (PWS). Currently, no treatment exists that addresses the multiple alterations associated with this rare neurodevelopmental disorder that significantly impact patients and their families. We will investigate the effects of daily, four-hour aVNT stimulation over a nine-month period on (a) emotion regulation, inclu

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: * Participant with PWS: Age : ≥ 18 years old; Diagnosis of Prader-Willi syndrome with identified genotype; Intellectual Quotient ≥ 55 measured by WAIS-IV (abbreviated version); Pathological or threshold score on at least one of the BRIEF-A subscales; Adults volunteering and able

Locations

Reference Center of Prader-Willi Syndrome (PRADORT)
Bordeaux, France
Reference Center of Prader-Willi Syndrome (CRMR PRADORT)
Hendaye, France
Reference Center of Prader-Willi Syndrome (PRADORT)
Paris, France
Reference Center of Prader-Willi Syndrome (PRADORT)
Toulouse, France

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →